Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine and Lenalidomide in Elderly Untreated AML
NCT00890929Phase 2Completed
- Sponsor
- Stanford University
- Start
- Apr 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in acute myeloid leukemia (AML), sponsored by Stanford University. Started Apr 2009; status: completed.
02
Drugs
lenalidomide
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00890929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00890929.